Transition Therapeutics closes $30.8 mln private placement deal
Transition Therapeutics Inc (TSX: TTH) has closed its previously announced private placement financing. Units of the company sold to U.S. investment firm Oracle Investment Management, Jack W. Schuler, Larry N. Feinberg and other investors generated US$17 million in gross proceeds, to be followed by an additional US$13.8 million within two years should investors exercise warrants. Based in Toronto, Transition Therapeutics is a biopharmaceutical company that develops novel therapeutics for disease indications with large markets.
23 June 2014•3 mins read
